Kezar Life Sciences, Inc. (KZR)
USD 6.29
(-3.53%)
USD 6.29
(-3.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 7 Million | - | - | - | - | - |
| Cost of Revenue | 77.08 Million | 1.02 Million | 1.51 Million | 1.54 Million | 1.3 Million | 690 Thousand |
| Gross Profit | -70.08 Million | -1.02 Million | -1.51 Million | -1.54 Million | -1.3 Million | -690 Thousand |
| Operating Expenses | 111.17 Million | 71.16 Million | 54.65 Million | 42.95 Million | 37.34 Million | 24.72 Million |
| Selling, General and Administrative Expenses | 26.54 Million | 20.15 Million | 15.72 Million | 11.96 Million | 9.97 Million | 6.59 Million |
| Research and Development Expenses | 85.69 Million | 51 Million | 38.93 Million | 30.98 Million | 27.36 Million | 18.13 Million |
| Other Expenses | 6.18 Million | - | - | - | - | - |
| Cost and Expenses | 112.23 Million | 71.16 Million | 54.65 Million | 42.95 Million | 37.34 Million | 24.72 Million |
| Operating Income | -105.23 Million | -71.16 Million | -54.65 Million | -42.95 Million | -37.34 Million | -24.72 Million |
| Interest Expense | 1.55 Million | 1.18 Million | 159 Thousand | - | - | - |
| Income Tax Expense | - | -2.92 Million | -1.35 Million | -2.75 Million | -3.55 Million | 1.55 Million |
| Earnings before Tax | -101.87 Million | -68.23 Million | -54.63 Million | -41.74 Million | -35.08 Million | -23.16 Million |
| Net Income | -101.87 Million | -65.31 Million | -53.27 Million | -38.99 Million | -31.53 Million | -23.16 Million |
| Earnings Per Share Basic | -1.40 | -0.97 | -1.01 | -0.89 | -1.65 | -2.26 |
| Earnings Per Share Diluted | -1.40 | -0.97 | -1.01 | -0.89 | -1.65 | -2.26 |
| Weighted Average Shares Outstanding | 72.55 Million | 67.36 Million | 52.75 Million | 44 Million | 19.08 Million | 10.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 72.55 Million | 67.36 Million | 52.75 Million | 44 Million | 19.08 Million | 10.26 Million |
| Gross Margin | -10.01 | - | - | - | - | - |
| EBIT Margin | -14.18 | - | - | - | - | - |
| Profit Margin | -14.55 | - | - | - | - | - |
| EBITDA | -99.25 Million | -66.11 Million | -52.96 Million | -40.25 Million | -34.42 Million | -22.47 Million |
| Earnings Before Tax Margin | -15.03 | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 7 Million | -5.42 Million | 7 Million | - |
| Cost of Revenue | 261 Thousand | 260 Thousand | 1.06 Million | 280 Thousand | 278 Thousand | 249 Thousand |
| Gross Profit | -261 Thousand | -260 Thousand | 5.93 Million | -5.7 Million | 6.72 Million | -249 Thousand |
| Operating Expenses | 21.64 Million | 23.45 Million | 111.17 Million | 28.12 Million | 32.52 Million | 26.78 Million |
| Selling, General and Administrative Expenses | 5.34 Million | 6.27 Million | - | 5.48 Million | 8.78 Million | 5.78 Million |
| Research and Development Expenses | 16.29 Million | 17.17 Million | - | 22.64 Million | 23.73 Million | 20.99 Million |
| Other Expenses | 1.48 Million | - | 6.18 Million | 6.18 Million | - | - |
| Cost and Expenses | 21.9 Million | 23.71 Million | 112.23 Million | 28.4 Million | 32.52 Million | 26.78 Million |
| Operating Income | -21.9 Million | -23.71 Million | -105.23 Million | -28.4 Million | -25.52 Million | -26.78 Million |
| Interest Expense | 401 Thousand | 400 Thousand | 1.55 Million | 399 Thousand | -396 Thousand | 385 Thousand |
| Income Tax Expense | - | 216.72 Thousand | 898.1 Thousand | -628 Thousand | -278 Thousand | 2.86 Million |
| Earnings before Tax | -21.54 Million | -21.65 Million | -101.87 Million | -32.25 Million | -23.1 Million | -24.3 Million |
| Net Income | -21.54 Million | -21.65 Million | -101.87 Million | -32.25 Million | -23.1 Million | -24.3 Million |
| Earnings Per Share Basic | -0.30 | -0.30 | - | -0.44 | -0.32 | -0.34 |
| Earnings Per Share Diluted | -0.30 | -0.30 | - | -0.44 | -0.32 | -0.34 |
| Weighted Average Shares Outstanding | 72.84 Million | 72.79 Million | 72.55 Million | 72.73 Million | 72.68 Million | 72.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 72.84 Million | 72.79 Million | 72.55 Million | 72.73 Million | 72.68 Million | 72.46 Million |
| Gross Margin | - | - | 0.85 | 1.05 | 0.96 | - |
| EBIT Margin | - | - | - | 5.18 | -3.65 | - |
| Profit Margin | - | - | -14.55 | 5.94 | -3.30 | - |
| EBITDA | -21.64 Million | -23.45 Million | - | -28.12 Million | -25.52 Million | -23.67 Million |
| Earnings Before Tax Margin | - | - | -15.03 | 5.23 | -3.65 | - |
PESI
FILATEX
NSC
MOTILALOFS
BVGG
AGS